当前位置: X-MOL 学术Hepatology › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40
Hepatology ( IF 12.9 ) Pub Date : 2022-09-02 , DOI: 10.1002/hep.32770
W Ray Kim 1 , Ajitha Mannalithara 1 , Paul Y Kwo 1 , C Andrew Bonham 2 , Allison Kwong 1
Affiliation  

Since the implementation of the model for end-stage liver disease (MELD) score to determine waitlist priority for liver transplant (LT) in 2002, the score has been capped at 40. Recently, the MELD 3.0 score was proposed to improve upon MELD-Na. Here, we examine waitlist mortality and LT outcomes in patients with MELD 3.0 ≥ 40 to assess the potential impact of uncapping the score.

中文翻译:


终末期肝病模型以上的终末期肝病患者死亡率 3.0 / 40



自2002年实施终末期肝病(MELD)评分模型以确定肝移植(LT)等候名单优先级以来,该评分上限一直为40分。最近,提出了MELD 3.0评分,以改进MELD-呐。在这里,我们检查了 MELD 3.0 ≥ 40 患者的候补死亡率和 LT 结局,以评估取消评分上限的潜在影响。
更新日期:2022-09-02
down
wechat
bug